Executives
-
Witherspoon CharlesVP & Treasurer -
Abraham SiljiSVP, Chief Technology Officer
-
Winters ChadVP, Chief Accounting Officer
-
Reiss-Clark CindyChief Commercial Officer
-
Mackay Kimberly BanksSVP, GC & Corporate Secretary
-
Lai Quintin JVP Strat & Investor Relations
-
Favorite Annette FSr. VP & Chief HR Officer
-
Birkett BernardSr VP, Chief Fin & Ops Off
?
Favorite Annette F
Sr. VP & Chief HR Officer
West Pharmaceutical Services, Inc.
US, Exton [HQ]
CIK
1654975
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
59,622,217
Price per Share :
$326.02
Equivalence :
$19,438,035,186.34
Transaction History
-
G59,622,217 Shares After TransactionValue : $n/a$0.0Transaction Date : 12/11/23
-
Footnotes
-
-
Footnotes:#1 Charitable contribution of shares to a donor advised fund
-
A65,032,217 Shares After TransactionValue : $n/a$0.0Transaction Date : 02/20/24
-
Footnotes
-
-
Footnotes:#1 2021 PSUs (PP20) award vesting net of taxes withheld.
-
M168,769,617 Shares After TransactionValue : $14,087,199,930.99$16,694,000.00Transaction Date : 08/30/23
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $413.58 to $414.57, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.#2 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $414.58 to $415.08, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
-
S161,169,617 Shares After TransactionValue : $66,754,843,665.23Sold $31,478,440.00Transaction Date : 08/30/23
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $413.58 to $414.57, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.#2 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $414.58 to $415.08, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
-
S148,769,617 Shares After TransactionValue : $61,726,001,789.47Sold $51,448,840.00Transaction Date : 08/30/23
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $413.58 to $414.57, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.#2 The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $414.58 to $415.08, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.